Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 28, 2008

View Archived Issues

Nissan Chemical patents novel antithrombocytopenic compounds

New therapeutic agents for thrombotic disorders described in recent patent literature

Novartis reports 2007 results

Regulatory T-cell loss of function triggers type 1 diabetes in mice

Epix achieves milestone in collaboration with Cystic Fibrosis Foundation

FDA Advisory Committee votes favorably for Entereg in postoperative ileus

New treatment options for inflammatory and allergic conditions disclosed in Icos patent

Nabi Biopharmaceuticals initiates new strategic alternatives process

Patient enrollment begins for NIH funded SFP clinical study

Bayer extends its liver cancer product portfolio in Japan

CombinatoRx provides update on 2008 goals

Combination of quetiapine and a mood stabilizer more effective in preventing mood episodes

Data Safety Monitoring Board reviews phase III defibrotide trial

First and only antiinflammatory pain relief patch available in the U.S.

GSK allies with institutions in tuberculosis and malaria drug discovery programs

GSK/MRC to identify new therapeutic targets from genetic association studies

M.D. Anderson and AstraZeneca form cancer-related neuropathic pain alliance

Protherics initiates OncoGel phase IIb study in esophageal cancer

BioCryst updates clinical development plan for intramuscular peramivir

Novartis reports positive primary endpoint from the FIRST-STEP study of Stalevo

Cangene's recombinant human growth hormone approved by the FDA

Kipres approved for additional indication of allergic rhinitis

Promising preclinical results for FGL in stress-induced cognitive deficits

Kirin Pharma launches Regpara tablets for secondary hyperparathyroidism

EMEA recommends approval of novel oral anticoagulant, Pradaxa

Clexane, sanofi-aventis' anticoagulant, is approved for marketing in Japan

Antibacterial Gracevit receives manufacturing and marketing approval in Japan

First launch of Optaflu in Germany

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...